The Clinical Features of FLAIR-Hyperintense Lesions in Anti-MOG Antibody Associated Cerebral Cortical Encephalitis with Seizures: Case Reports and Literature Review
- PMID: 34177880
- PMCID: PMC8231650
- DOI: 10.3389/fimmu.2021.582768
The Clinical Features of FLAIR-Hyperintense Lesions in Anti-MOG Antibody Associated Cerebral Cortical Encephalitis with Seizures: Case Reports and Literature Review
Abstract
Background: The presence of fluid attenuated inversion recovery (FLAIR)-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated cerebral cortical encephalitis with seizures (FLAMCES) was recently reported. However, the clinical characteristics and outcome of this rare clinico-radiographic syndrome remain unclear.
Methods: The present study reported two new cases. In addition, cases in the literature were systematically reviewed to investigate the clinical symptoms, magnetic resonance imaging (MRI) abnormalities, treatments and prognosis for this rare clinico-radiographic syndrome.
Results: A total of 21 cases were identified during a literature review, with a mean patient age at onset of 26.8 years. The primary clinicopathological characteristics included seizures (100%), headache (71.4%), fever (52.3%) and other cortical symptoms associated with the encephalitis location (61.9%). The common seizure types were focal to bilateral tonic-clonic seizures (28.6%) and unknown-onset tonic-clonic seizures (38.1%). The cortical abnormalities on MRI FLAIR imaging were commonly located in the frontal (58.8%), parietal (70.6%) and temporal (64.7%) lobes. In addition, pleocytosis in the cerebrospinal fluid was reported in the majority of the patients (95.2%). All patients received a treatment regimen of corticosteroids and 9 patients received anti-epileptic drugs. Clinical improvement was achieved in all patients; however, one-third of the patients reported relapse following recovery from cortical encephalitis.
Conclusions: FLAMCES is a rare phenotype of MOG-associated disease. Thus, the wider recognition of this rare syndrome may enable timely diagnosis and the development of suitable treatment regimens.
Keywords: cortical; encephalitis; fluid attenuated inversion recovery; myelin oligodendrocyte glycoprotein; seizure.
Copyright © 2021 Wang, Liu, Lin, Liang, Zhao and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody.Front Immunol. 2023 Jul 14;14:1203615. doi: 10.3389/fimmu.2023.1203615. eCollection 2023. Front Immunol. 2023. PMID: 37520572 Free PMC article.
-
[Cingulate seizure as a clinical manifestation of anti-myelin oligodendrocyte glycoprotein antibody-positive cerebral cortical encephalitis of two cases].Rinsho Shinkeigaku. 2023 Jul 22;63(7):441-449. doi: 10.5692/clinicalneurol.cn-001724. Epub 2023 Jun 30. Rinsho Shinkeigaku. 2023. PMID: 37394493 Japanese.
-
Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: A case report and literature review.Seizure. 2022 May;98:13-18. doi: 10.1016/j.seizure.2022.04.001. Epub 2022 Apr 3. Seizure. 2022. PMID: 35397246 Review.
-
Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome.J Neurol. 2019 Oct;266(10):2481-2487. doi: 10.1007/s00415-019-09440-8. Epub 2019 Jun 26. J Neurol. 2019. PMID: 31243540
-
MOG antibody-positive cerebral cortical encephalitis: Two case reports and literature review.Int J Dev Neurosci. 2021 Jun;81(4):342-351. doi: 10.1002/jdn.10106. Epub 2021 Mar 29. Int J Dev Neurosci. 2021. PMID: 33756004 Review.
Cited by
-
Less common phenotypes of myelin oligodendrocyte glycoprotein antibody-related diseases in children deserve more attention.Pediatr Res. 2024 Mar 4. doi: 10.1038/s41390-024-03058-x. Online ahead of print. Pediatr Res. 2024. PMID: 38438553
-
Clinical Features of Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Isolated Seizure Symptoms.Neuropsychiatr Dis Treat. 2024 Jan 16;20:61-67. doi: 10.2147/NDT.S444853. eCollection 2024. Neuropsychiatr Dis Treat. 2024. PMID: 38249524 Free PMC article.
-
Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody.Front Immunol. 2023 Jul 14;14:1203615. doi: 10.3389/fimmu.2023.1203615. eCollection 2023. Front Immunol. 2023. PMID: 37520572 Free PMC article.
-
Clinical characteristic of myelin oligodendrocyte glycoprotein antibody associated cortical encephalitis in adults and outcomes following glucocorticoid therapy.Front Aging Neurosci. 2023 Jan 4;14:1076361. doi: 10.3389/fnagi.2022.1076361. eCollection 2022. Front Aging Neurosci. 2023. PMID: 36688157 Free PMC article.
-
A unilateral FLAIR-hyperintense lesions in anti-MOG-associated encephalitis with seizures (FLAMES) case from a developing country: A case report.Ann Med Surg (Lond). 2022 Nov 12;84:104881. doi: 10.1016/j.amsu.2022.104881. eCollection 2022 Dec. Ann Med Surg (Lond). 2022. PMID: 36582878 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
